Every year, about 300,000 people die because of pesticide poisoning worldwide. The most common pesticide agents are organophosphates and phosphides, aluminium phosphide (AlP) in particular. AlP is known as a suicide poison that can easily be bought and has no effective antidote. Its toxicity results from the release of phosphine gas as the tablet gets into contact with moisture. Phosphine gas primarily affects the heart, lungs, gastrointestinal tract, and kidneys. Poisoning signs and symptoms include nausea, vomiting, restlessness, abdominal pain, palpitation, refractory shock, cardiac arrhythmias, pulmonary oedema, dyspnoea, cyanosis, and sensory alterations. Diagnosis is based on clinical suspicion, positive silver nitrate paper test to phosphine, and gastric aspirate and viscera biochemistry. Treatment includes early gastric lavage with potassium permanganate or a combination with coconut oil and sodium bicarbonate, administration of charcoal, and palliative care. Specifi c therapy includes intravenous magnesium sulphate and oral coconut oil. Moreover, acidosis can be treated with early intravenous administration of sodium bicarbonate, cardiogenic shock with fl uid, vasopresor, and refractory cardiogenic shock with intra-aortic baloon pump or digoxin. Trimetazidine may also have a useful role in the treatment, because it can stop ventricular ectopic beats and bigeminy and preserve oxidative metabolism. This article reviews the epidemiological, toxicological, and clinical/pathological aspects of AlP poisoning and its management.
Aluminium phosphide (AlP) is a well known, highly effective outdoor and indoor insecticide and rodenticide. It is readily available in Asian markets such as India. Although its use has been banned in Iran, it is still used to protect rice (hence the local name "rice tablet") and stored grains from rodents and other household pests.
Moisture in the air mixes with phosphide grains and sets off phosphine (hydrogen phosphide, phosphorus trihydride, PH 3 ), which is the active form of the pesticide. Tablets, pellets, or compressed discs contain phosphide and other substances such as ammonium carbonate. If it comes into contact with an acid, phosphine is released even more vigorously. Two kinds of acute poisoning have been reported: indirect inhalation of phosphine released during approved use or direct ingestion of metal phosphides (1, 2) .
In an autopsy study of unnatural deaths in Northwest India (1), AlP was found to be the most common suicidal poison, causing 68.4 % of total deaths due to poisoning between 1992 and 2002. This epidemic of suicidal AlP poisoning has also been confi rmed by Gupta and Ahlawat (2) . Between 1977 and 1987, barbiturates (33.3 %), organophosphates (23.8 %) , and copper sulphate (14.3 %) were the most common causes of death by poisoning and between 1987 and RESEARCH We looked up the terms aluminium, aluminium phosphide, and phosphine in bibliographical databases such as the TUMS digital library, Pubmed, Scopus, and Google Scholar. This review includes relevant articles published between 1990 and 2011.
Epidemiology
Every year, about 300,000 deaths due to pesticide poisoning are reported worldwide (10) . Most reports of acute pesticide poisoning are based on hospital admission records and refl ect only a fraction of the real incidence. Most reports of AlP poisoning refer to the young adult population from rural Asian areas (4) . In Asia, about 25 million agricultural workers report an episode of poisoning every year (11) . In a study conducted in Tehran, Shadnia et al. (3) found that of 77,958 poisonings, 471 people were poisoned with AlP , of whom 146 (31 %) died. This makes AlP a major concern in the Iranian population (3, 12) .
Of 188 cases of phosphine poisoning reported in Germany between 1983 and 2003, 28 % were intentional, mostly by ingestion, which ended in two fatalities, whereas 65 % were accidental, mostly by inhalation, due to inappropriate self-protection from the released gas, which resulted in only transient gastrointestinal (GI) and respiratory symptoms (13) . In the UK, the majority of 93 AlP poisonings reported to the National Poisons Information Service between 1997 and 2003 were accidental and concerned limited exposure to phosphine gas in agricultural locations (4) . Only one fatal outcome was reported in this case series.
Mechanism of action
The exact mechanism of action of AlP is still unknown. However some initial studies on different animals showed that phosphine mainly binds cytochrome oxidase and changes the valences of the haem component of haemoglobin (14) . It also induces oxidative stress and boosts extra-mitochondrial release of free oxygen radicals (15) that results in lipid peroxidation and protein denaturation of the cell membrane (16, 17) in various organs. Abdollahi et al. (18) believe that oxidative stress is one of the main mechanisms of action of AlP toxicity that is somehow similar to that of organophosphate (OP) compounds. Furthermore, AlP reduces glutathione, which is one of the main antioxidant defences. In fact, AlP and OP alike cause a toxic stress that is accompanied by changes in glucose metabolism (19, 20) . Al-Azzawi et al. (21) showed that in vitro exposure to phosphine leads to reduction of human serum cholinesterase activity, depending on the duration and phosphine concentration. On the other hand, some studies found no change in erythrocyte cholinesterase activity in accidental phosphine inhalation cases (22) . Figure 1 shows a plausible mechanism of AlP toxicity.
Toxicokinetics
Judging by the rapid systemic toxicity, phosphine is quickly absorbed after oral ingestion. Phosphine is released as soon as AlP or other phosphide salts get in contact with hydrochloric acid of the stomach (23) .
In vitro studies (24) (25) (26) (27) suggest that phosphides are absorbed as microscopic particles of unhydrolysed salt that permanently interact with free haemoglobin and haemoglobin in intact erythrocytes (rat and human) to produce a haemichrome (a methaemoglobin derivative resulting from distorted protein conformation). In addition, Potter et al. (26) report that Heinz bodies (denatured haemoglobin aggregates) are formed when phosphide concentration in vitro exceeds 1.25 μg mL -1 . Reports of in vivo phosphide poisoning showed intravascular complications such as haemolysis and methaemoglobinaemia, which support the involvement of erythrocytes in the biotransformation of phosphine in humans (24) . Phosphine is excreted in the urine as hypophosphite and is also exhaled in the unchanged form (8) .
Organ toxicity
The lethal dose of AlP is around 0.5 g. Those who survived had either taken a very small amount, the tablet expired or phosphine gas evaporated because the tablet had been exposed to air. AlP poisoning affects most of the organs. Early symptoms include nausea, vomiting, retrosternal and epigastric pain, dyspnoea, anxiety, agitation, and garlic breath (28) (29) (30) . The early signs of fatal toxicity (90 % to 100 %) are shock and peripheral circulatory failure (31) . Histopathological changes such as central venous congestion, degeneration of hepatocytes, and mononuclear infi ltration are usually seen in the liver of poisoned patients. Furthermore, Mehrpour et al. (23) report alveolar thickening and dilated capillaries in the lung, degeneration of Nissl granule in the brain cytoplasm, degenerated eccentric nucleus in the cortex, and congestion within glomerulus and intraparenchymal part of the kidney.
Gastrointestinal toxicity
The early gastrointestinal symptoms of AlP ingestion include haematemesis, vomiting and epigastric pain. Endoscopy reveals corrosive lesions of the oesophagus and stomach, severe gastric erosions, duodenal erosions, and oesophageal strictures or fi stula. Dysphagia is a common late complication (32) (33) (34) (35) (36) . In our previous study, we described a family (a 35-year-old woman with her 18-year-old daughter and a 6-year-old son) who were accidentally poisoned with phosphine gas. They all had intensive abdominal pain, hyperglycaemia, hypotension, and severe thirst, and the boy died because of cardiopulmonary arrest before admission to the hospital (37) .
A case of benign oesophagobronchial fistula secondary to AlP poisoning in a 17-year-old boy was reported recently. The patient presented with acute dysphagia and severe cough following every swallow of either a liquid or solid fi ve to six days after AlP tablet ingestion (38) .
In another report (39) , dysphagia was observed in 38.87 % of survivors after a mean interval of 38.6 days from the day of AlP poisoning. Oesophageal strictures were seen in 32.2 % of the survivors. Two patients reported a tracheo-oesophageal fi stula 20 cm to 22 cm from the incisors (39) .
Hepatic toxicity
Jaundice as a clinical and laboratory indicator of liver damage is sometimes observed, but reports are controversial (31) . Jaundice can even be a manifestation of another disturbances such as intravascular haemolysis (29) . A more common fi nding is transient elevation of serum aspartate and alanine aminotransferase (40) (41) (42) (43) . The main histopathological fi ndings in the liver at autopsy of fatal phosphine poisoning include cytoplasmic vacuolisation of hepatocytes and sinusoidal congestion. Nuclear fragmentation and sinusoidal clusters of polymorphonuclear leukocytes in the liver were also reported (44) .
Respiratory toxicity
Tachypnoea, dyspnoea, crepitations and rhonchi are common signs of respiratory toxicity. Respiratory distress syndrome and other types of pulmonary oedema are common in adults, accompanied by protein-rich or haemorrhagic pleural effusions (2, 31, (45) (46) (47) .
Cardiac toxicity
Post-mortem reports of cardiac toxicity include heart failure (6), profound and refractory hypotension (42) , heart congestion, subendocardial infarction or pericarditis, separation of myocardial fibres by oedema, fragmentation of the fi bres, non-specifi c vacuolation of myocytes, focal necrosis, and neutrophil and eosinophil infi ltration (41, 48, 49) . Other signs and symptoms include, increased left ventricle, hypokinesia of the left ventricle and septum, akinesia, lower ejection fraction, severe hypotension, raised systemic venous pressure, normal pulmonary artery wedge pressure, inadequate systemic vasoconstriction, and electrocardiographic (ECG) abnormalities (2, 50-52) such as dysrhythmia, ST-T wave changes and conduction defects. Sinus tachycardia dominates in the fi rst three to six hours of poisoning, followed by ST-T changes and conduction disturbances between hour 6 and twelve, and then by arrhythmias (49). Siwach et al. (53) found ventricular tachycardia in 40 %, ventricular fi brillation in 23.3 %, supraventricular tachycardia in 46.7 %, and atrial fl utter/fi brillation in 20 % of AlP-poisoned patients.
Electrolyte and metabolic abnormalities
Hypokalaemia (primary or secondary to vomiting), metabolic acidosis or mixed metabolic acidosis, respiratory alkalosis, and acute renal failure have often been reported (24) . Hyperkalaemia, hypo-and hypernatraemia have also been observed in AlP poisoning, and these changes were associated with a higher mortality rate (54) .
In experimental models, AlP may alter glucose homeostasis; it signifi cantly decreases plasma glucose in AlP-treated rats (55) and horses (56) . Hypoglycaemia has also been reported in other studies (40, (57) (58) (59) . Some studies have reported a hyperglycaemic effect of AlP (9, 37, 60) and some suggested that hyperglycaemia may be an important prognostic factor in AlP poisoning (61, 62) , although not specifi c for AlP alone (20) . In our earlier study, blood glucose was significantly higher in people who died of AlP poisoning than in those who survived (61) . Controversial fi ndings of blood sugar may refl ect a wide variety of changes in magnesium, calcium, phosphate, citrate, and cortisol levels (60) . Some studies reported increased blood magnesium in AlP poisoning (31, 52, 63) and other reported hypomagnesaemia (64) (65) (66) (67) . Moreover, some studies (68, 69) found no change in blood magnesium. These differences between reports may also point to differences between analytical methods used.
Mehrpour et al. (23) have also reported that arrested oxidative phosphorylation and poor tissue perfusion may lead to lactic acidosis.
Other effects
Hepatitis, pancreatitis, acute adrenocortical insuffi ciency, acute tubular necrosis, and disseminated intravascular coagulation are less common fi ndings in AlP poisoning (24) . Refractory shock may result in cerebral anoxia that usually presents itself as drowsiness, delirium, and coma. Another uncommon sign is methaemoglobinaemia (27, 70) .
There are interesting reports about spontaneous ignition and burns that occurred after oral poisoning with AlP (71-73). Phosphine gas is infl ammable, depending on temperature and pressure. The absolute limit of fl ammability for phosphine in air is 1.8 % (17.9 mg mm -3 ). When this limit is exceeded, phosphine can explode. Diphosphine, which is a product of the reaction between AlP and acid or moisture, burns spontaneously, reacting instantly with oxygen in the air, and this is one of the causes of explosions occurring during fumigation of storage grains (73) . To prevent self-ignition AlP is mixed in the tablets with aluminium carbonate in the ratio 56:44, respectively (72) .
Sequelae in survivors?
Only a few articles have described long-term disabilities due to AlP poisoning. Brautbar and Howard (74) described two patients, one with a longterm peripheral neuropathy, weakness and loss of sensation in the left-side extremities, severe headaches, fatigue, and dizziness and the other with the obstructive airway disease and headache (74) . Kurzbauer and Kiesler (75) described a case of AlP poisoning with neurological abnormalities, such as Romberg, Rossolimo reflex on the left side, and bilateral Babinski. The neurological symptoms continued for 1.5 years post AlP exposure. Jain et al. (39) reported dysphagia, oesophageal strictures, and tracheoesophageal fi stula in survivors a month after AlP exposure.
Diagnosis of poisoning
Although the diagnosis of AlP poisoning is often based on clinical suspicion or reports, a range of chemical and analytical tests are there to confi rm it. One simple and sensitive spot test for the detection of phosphine gas in gastric fl uid or breath is the silver nitrate test (76) . Another test that can be performed on the gastric content is the ammonium molybdate test, which is both qualitative and quantitative (77) . Gas chromatography is the most specifi c and sensitive method for detecting the presence of phosphine in blood/air and can detect even minute amounts of phosphine in the air (78) .
Other salts of phosphide such as zinc phosphide (ZnP) are also available in some countries that have the same mechanism of toxicity as AlP, but lower human mortality (79) . Analytical tests help us to distinguish between AlP and ZnP poisoning and make a more accurate prognosis of the outcome. Hydrochloric acid is added to the sample (gastric contents or tissue), the mixture is heated, ammonium chloride and ammonium hydroxide added to the fi ltrate, and if the resulting gelatinous precipitate is white, it indicates the presence of Al (4).
Management of poisoning
Without a specifi c antidote, the management of AlP poisoning is very limited, mostly supportive. It is important do diagnose it as early as possible (see above). Before starting the treatment, medical staff should protect themselves with a full-face mask and rubber gloves. In cases of inhalation poisoning, the patient should be transferred to a well-ventilated space or fresh air. Contaminated clothes should be removed, and skin and eyes washed with tap water immediately. Gastric lavage with potassium permanganate, activated charcoal+sorbitol solution, and coconut oil can be performed in the fi rst emergency step (80) . Potassium permanganate (1:10 000 solution) oxidises phosphine gas in the stomach to phosphate, and reduces the amount of lethal phosphine gas (9, 80) . Although charcoal is generally used for reducing phosphine absorption in the gastrointestinal system, no study has proved its effi cacy in humans.
Bajwa et al. (81) recommended extensive gastric lavage with a mixture of sodium bicarbonate solution and coconut oil. The acidic environment of the stomach stimulates the conversion of AlP to phosphine gas, and lavage with sodium bicarbonate can be helpful.
Cardiac monitoring should include blood pressure and ECG to prevent arrhythmias and maintain tissue perfusion and oxygenation. One of the most common results of AlP toxicity is myocardial injury and haemodynamic instability (82) .
Another necessary step in the management of AlP poisoning is early resuscitation with fluid and vasoactive agents to control central venous pressure (CVP) or pulmonary artery wedge pressure (PAWP). Norepinephrine or phenylephrine, dopamine, and dobutamine can be used to treat hypotension and refractory shock, while anti-arrhythmic agents, DC cardioversion, and temporary pacemaker should address the arrhythmia. Intra-aortic balloon pump (IABP) is a good way to mechanically support the heart, especially in toxic myocarditis with refractory shock (84) . Trimetazidine has also proven itself effective recently in stopping ventricular ectopic beats and preserving oxidative metabolism (67) . In addition, digoxin can be used to stabilise the left ventricular heart failure (82) .
Early diagnosis of organ damage is another important aspect in the management, as AlP poisoning affects virtually all organs in the body. Acute lung injury may need endotracheal intubation and mechanical ventilation. Cyanosis not responding to oxygen therapy may be a sign of methaemoglobinaemia that requires therapy with intravenous methylene blue (1 % solution) in the dose of 2 mg kg -1 of body weight over fi ve minutes. For metabolic acidosis, intravenous sodium bicarbonate should be considered, whereas severe acidosis, volume overload or renal failure may require haemodialysis. However, haemodialysis is probably not very effective in removing phosphine (8) . These new therapeutic approaches have been summarised in Table 1 .
Magnesium supplementation
It is diffi cult to decide whether to give supplemental magnesium or not. Treatment with magnesium sulphate has been reported to reduce mortality by up to 50 % (2, 49, 65, 66) . Magnesium stabilises the cell membrane and acts as an anti-oxidant. A study published in 1994 (69) compared treatments of AlPpoisoned patients and concluded that the survival rate of those who received supplemental magnesium was not signifi cantly better than of those who did not (42 % vs. 40 %, respectively). In contrast, in another case control study (65) , magnesium improved survival of patients who ingested high doses of AlP. Moreover, a recent study (84) on a rat model showed that 25 Mg ‫2‬ + -carrying nanoparticle ( 25 MgPMC16) significantly increased blood pressure and heart rate of rats poisoned with AlP. This study also demonstrated that 25 MgPMC16 increased intracardiac magnesium levels, reduced lipid peroxidation, and improved mitochondrial function.
Hyperinsulinaemia-euglycaemia and hyperventilation oxygenation
Some authors propose that a combination of hyperinsulinaemia-euglycaemia and hyperventilation oxygenation is worthy of more extensive evaluation as a therapy for AlP poisoning (85) .
N-acetylcysteine
Different studies in rats (86, 87) and humans (66) have revealed that N-acetylcysteine can help as it replenishes cellular glutathione and magnesium, in addition to its antioxidant properties. In rats exposed to AlP, N-acetylcysteine increased survival time and reduced myocardial oxidative injury (4).
Coconut and almond oil
There are reports of the positive clinical effects of coconut oil against AlP poisoning in humans (9, 86) . Its mechanism of action is unclear, but it may form a protective layer around the gastric mucosa and prevent the absorption of phosphine gas. In addition, coconut oil may dilute HCl in the stomach and reduce the breakdown of phosphide.
Saidi and Shoajaie (88) reported that intragastric lavage with sweet almond oil considerably reduced the mortality of rats poisoned with AlP. It also signifi cantly lowered plasma cholinesterase levels. The authors suggested that sweet almond oil should be given orally immediately after AlP ingestion, but this has yet to be confi rmed in humans.
Hyperbaric oxygenation
Saidi et al. (89) found that hyperbaric oxygenation improved the survival time in rats poisoned with AlP. However, its efficacy in humans has not been investigated.
Digoxin
It has been hypothesised that treatment with digoxin (rapid digitalisation) would increase myocardial contractility and blood pressure (90) , countering thus the direct effects of AlP on cardiac myocytes which lead to refractory cardiogenic shock. Mehrpour et al. (82) have recently reported about successful treatment of an 18-year-old girl who had ingested a 3 g AlP tablet. On hospital admission her blood pressure was undetectable and she had a severe left ventricular systolic dysfunction. She received dopamine (10 μg kg -1 min -1 ) and digoxin (0.5 mg) every six hours during the fi rst day and continued with 0.25 mg per day on the following days. The ECG parameters became normal on day three, and she was discharged on day 10 fully recovered.
Hydroxyethyl starch
Another option for the management of AlP poisoning is hydroxyethyl starch (91) . Leakage of fl uids from intravascular to extravascular space that leads to a strong refractory hypotension is one of the post-mortem fi ndings in AlP poisoning. Hydroxyethyl starch remains in the intravascular space as a colloid rather than as a crystalloid and thus reduces the extravascular leak of albumin and fluids (91) . However, no experiment has yet investigated the use of starch in the management of AlP poisoning.
Prognosis of AlP poisoning
The mortality in adults who have ingested 500 mg of AlP or over is between 30 % and 100 %. The higher the blood phosphine, the higher the mortality. Patients having blood phosphine levels equal to or less than 1.067±0.16 mg survived, and this dose seems to be the lethal threshold of phosphine toxicity (92) . Survival may increase if a very small amount of AlP is ingested or the tablet has expired or was exposed to air (12) . Vomiting and early supportive care also increase the survival rate (8) .
Poor prognosis is indicated by hyperglycaemia, high simplifi ed acute physiology score (SAPS II), hypotension, acidosis, leukocytosis, hyperuraemia, ECG abnormalities, high acute physiology and chronic health evaluation score (APACHE II), low Glasgow coma scale, acute renal failure, low prothrombin rate, hyperleukocytosis, methaemoglobinaemia, use of vasoactive drugs, lack of vomiting after ingestion, and use of mechanical ventilation (4, 61, 70, 93, 94) .
To conclude, acute AlP poisoning is a worldwide problem. The understanding of its mechanisms of toxicity and clinical effects has improved in the recent years. An antidote proper for phosphine poisoning is still unavailable. A number of possibilities for treatment have been tried out or experimented with, but they all need further validation (see Table 1 ). Meanwhile, preventive measures might help to control the risk of poisoning in humans such as limited access to phosphide compounds, regulations to ban its use as a pesticide, and keeping health professionals abreast with the latest knowledge about early management of phosphide poisoning.
Sažetak

SUSTAVNI PREGLED OTROVANJA ALUMINIJEVIM FOSFIDOM
Svake godine u svijetu oko 300.000 ljudi umre od trovanja pesticidima. Najčešći pesticidni spojevi su organofosfati i fosfi di, ponajviše aluminijev fosfi d. On je poznat kao otrov samoubojica, jer ga je lako nabaviti, a nema djelotvornoga protuotrova. Toksičnost duguje otpuštanju fosfi nskoga plina u trenutku kada tableta dođe u dodir s vlažnim okružjem. Fosfi nski plin ponajviše djeluje na srce, pluća, probavni sustav i bubrege. Znakovi i simptomi trovanja obuhvaćaju mučninu, povraćanje, uznemirenost, bol u trbuhu, lupanje srca, refraktorni šok, srčane aritmije, plućni edem, dispneju, cijanozu i osjetilne promjene. Dijagnoza se zasniva na kliničkom opažanju, pozitivnom nalazu testa na fosfi n sa srebrnim nitratom, aspiratu iz želuca te biokemiji crijeva. Otkrije li se rano, liječenje obuhvaća ispiranje želuca kalijevim permanganatom, odnosno kombinacijom kokosova ulja i natrijeva bikarbonata, aktivni ugljen te palijativnu skrb. Usmjereno liječenje obuvhaća intravensku primjenu magnezijeva sulfata i kokosova ulja. Korisnim se može pokazati liječenje acidoze ranom intravenskom primjenom natrijeva bikarbonata i liječenje srčanoga šoka odgovarajućom tekućinom i vazopresorom te refraktornog šoka, intraaortalnim balonom odnosno digoksinom. Korisnim se može pokazati i trimetazidin, budući da sprječava ventrikularne ekstrasistole i bigeminiju te čuva oksidativni metabolizam. Ovaj članak donosi pregled različitih vidova trovanja aluminijevim fosfi dom, uključujući njegovu epidemiologiju, toksičnost, kliničke znakove i simptome te medicinsku obradu. 
